Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $19.1B |
| FY2017, ended Dec 31, 2017 | $27.5B |
| FY2018, ended Dec 31, 2018 | $14.9B |
| FY2019, ended Dec 31, 2019 | $19.0B |
| FY2020, ended Dec 31, 2020 | $37.9B |
| FY2021, ended Dec 31, 2021 | $60.7B |
| FY2022, ended Dec 31, 2022 | $54.4B |
| FY2023, ended Dec 31, 2023 | $61.1B |
| FY2024, ended Dec 31, 2024 | $54.7B |
| FY2025, ended Dec 31, 2025 | $73.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $90.3B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $14.8B |
| FY2017, ended Dec 31, 2017 | $16.4B |
| FY2018, ended Dec 31, 2018 | $18.9B |
| FY2019, ended Dec 31, 2019 | $14.4B |
| FY2020, ended Dec 31, 2020 | $14.2B |
| FY2021, ended Dec 31, 2021 | $22.8B |
| FY2022, ended Dec 31, 2022 | $23.3B |
| FY2023, ended Dec 31, 2023 | $22.9B |
| FY2024, ended Dec 31, 2024 | $25.5B |
| FY2025, ended Dec 31, 2025 | $25.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $25.9B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$4.15B | $924M |
| FY2017, ended Dec 31, 2017 | $1.82B | $3.26B |
| FY2018, ended Dec 31, 2018 | $2.60B | $1.89B |
| FY2019, ended Dec 31, 2019 | −$239M | −$1.17B |
| FY2020, ended Dec 31, 2020 | $599M | $1.06B |
| FY2021, ended Dec 31, 2021 | $4.31B | $5.60B |
| FY2022, ended Dec 31, 2022 | $3.47B | $1.67B |
| FY2023, ended Dec 31, 2023 | $1.85B | $455M |
| FY2024, ended Dec 31, 2024 | $1.89B | $2.35B |
| FY2025, ended Dec 31, 2025 | $2.20B | $1.12B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.94B | — |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $4.25B |
| FY2017, ended Dec 31, 2017 | $4.53B |
| FY2018, ended Dec 31, 2018 | $4.22B |
| FY2019, ended Dec 31, 2019 | $2.02B |
| FY2020, ended Dec 31, 2020 | $3.66B |
| FY2021, ended Dec 31, 2021 | $8.07B |
| FY2022, ended Dec 31, 2022 | $8.15B |
| FY2023, ended Dec 31, 2023 | $4.76B |
| FY2024, ended Dec 31, 2024 | $3.92B |
| FY2025, ended Dec 31, 2025 | $3.82B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.08B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.23B |
| FY2017, ended Dec 31, 2017 | $13.2B |
| FY2018, ended Dec 31, 2018 | $11.1B |
| FY2019, ended Dec 31, 2019 | $9.83B |
| FY2020, ended Dec 31, 2020 | $9.71B |
| FY2021, ended Dec 31, 2021 | $9.45B |
| FY2022, ended Dec 31, 2022 | $10.6B |
| FY2023, ended Dec 31, 2023 | $9.42B |
| FY2024, ended Dec 31, 2024 | $8.95B |
| FY2025, ended Dec 31, 2025 | $9.38B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $9.39B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 0.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.45B |
| FY2017, ended Dec 31, 2017 | 1.45B |
| FY2018, ended Dec 31, 2018 | 1.45B |
| FY2019, ended Dec 31, 2019 | 1.45B |
| FY2020, ended Dec 31, 2020 | 1.46B |
| FY2021, ended Dec 31, 2021 | 1.45B |
| FY2022, ended Dec 31, 2022 | 1.43B |
| FY2023, ended Dec 31, 2023 | 1.43B |
| FY2024, ended Dec 31, 2024 | 1.44B |
| FY2025, ended Dec 31, 2025 | 1.44B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.44B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | — | $86.0M | $1.51B |
| FY2017, ended Dec 31, 2017 | — | $71.0M | $0 |
| FY2018, ended Dec 31, 2018 | — | $76.0M | $3.50B |
| FY2019, ended Dec 31, 2019 | $0 | $63.0M | — |
| FY2020, ended Dec 31, 2020 | $0 | $99.0M | — |
| FY2021, ended Dec 31, 2021 | $488M | $98.0M | — |
| FY2022, ended Dec 31, 2022 | $1.35B | $95.0M | — |
| FY2023, ended Dec 31, 2023 | $0 | $109M | — |
| FY2024, ended Dec 31, 2024 | $59.0M | $109M | — |
| FY2025, ended Dec 31, 2025 | $107M | $121M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $203M | $150M | — |
Valuation
At current price- Market Cap
- $94.7B
- P/E
- 32.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.7×
- Price / Book
- 4.7×
- EV / EBITDA
- 11.0×
Growth
Trailing 12 months- Revenue (TTM)
- $25.9B
- Revenue Growth YoY
- 0.2%
- Revenue CAGR 3Y
- 3.7%
- Revenue CAGR 5Y
- 12.8%
- EPS Growth YoY
- —. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- 53.1%
Profitability
Trailing 12 months- Gross Margin
- 27.1%
- Operating Margin
- 26.8%
- Net Margin
- 11.4%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 15.4%
Earnings
Trailing 12 months- Net Income
- $2.94B
- EPS (diluted)
- —
- EBITDA
- $9.07B
- Operating Income
- $6.92B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $4.08B
- Total Debt
- $9.39B
- Net Debt
- $5.31B
- Total Assets
- $59.7B
- Total Liabilities
- $27.5B
- Shareholders' Equity
- $20.1B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.90B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 0.9%
- Dividend / Share
- $0.60
- Beta (5Y)
- 1.40
Every ratio is calculated from the company’s reported figures.